GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHF) » Definitions » PS Ratio

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) PS Ratio : 1.79 (As of Apr. 27, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Aspen Pharmacare Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aspen Pharmacare Holdings's share price is $9.205. Aspen Pharmacare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.14. Hence, Aspen Pharmacare Holdings's PS Ratio for today is 1.79.

Warning Sign:

Aspen Pharmacare Holdings Ltd stock PS Ratio (=2.36) is close to 2-year high of 2.4

The historical rank and industry rank for Aspen Pharmacare Holdings's PS Ratio or its related term are showing as below:

APNHF' s PS Ratio Range Over the Past 10 Years
Min: 0.89   Med: 2.8   Max: 7.17
Current: 2.25

During the past 13 years, Aspen Pharmacare Holdings's highest PS Ratio was 7.17. The lowest was 0.89. And the median was 2.80.

APNHF's PS Ratio is ranked worse than
51.74% of 1003 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs APNHF: 2.25

Aspen Pharmacare Holdings's Revenue per Sharefor the six months ended in Dec. 2023 was $2.55. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.14.

During the past 12 months, the average Revenue per Share Growth Rate of Aspen Pharmacare Holdings was 11.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 2.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.50% per year.

During the past 13 years, Aspen Pharmacare Holdings's highest 3-Year average Revenue per Share Growth Rate was 33.40% per year. The lowest was -6.50% per year. And the median was 18.50% per year.

Back to Basics: PS Ratio


Aspen Pharmacare Holdings PS Ratio Historical Data

The historical data trend for Aspen Pharmacare Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings PS Ratio Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.95 1.96 1.63 2.00

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.63 - 2.00 -

Competitive Comparison of Aspen Pharmacare Holdings's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's PS Ratio falls into.



Aspen Pharmacare Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Aspen Pharmacare Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=9.205/5.143
=1.79

Aspen Pharmacare Holdings's Share Price of today is $9.205.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aspen Pharmacare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Aspen Pharmacare Holdings  (OTCPK:APNHF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Aspen Pharmacare Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019